基于mRNA的疗法临床试验的现状
Qun Li1,2, Meiling Zeng1,2, Wang Lv1
1Department of Pharmacy, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang, China.
Human vaccines & immunotherapeutics
|February 23, 2026
概括
使者RNA (mRNA) 疗法显示出超越COVID-19疫苗的广泛潜力. 对557项临床试验的分析揭示了对传染病的关注,大多数研究都处于早期阶段,并由行业资助,突出了需要更多的第三阶段数据的需求.
科学领域:
- 生物技术和制药科学 生物技术和制药科学
- 临床研究和开发 临床研究和开发
- 分子医学是分子医学.
背景情况:
- 使者RNA (mRNA) 疗法正在扩展到COVID-19疫苗之外的各种治疗领域.
- 了解当前的临床研究环境对于指导未来发展至关重要.
- 全球临床试验数据为基于mRNA的治疗方法的进展和重点提供了洞察力.
研究的目的:
- 综合分析和总结基于mRNA的治疗方法的全球临床试验格局.
- 确定注册的mRNA临床试验的关键特征,趋势和地理分布.
- 为mRNA疗法领域的研究人员和利益相关者提供参考.
主要方法:
- 在ClinicalTrials.gov (CTg) 和中国临床试验注册表 (ChiCTR) 登记的mRNA临床试验的系统分析,截至2025年6月7日.
- 提取和分析了12个关键数据点,包括疾病目标,干预措施,试验阶段,赞助商和地点.
- 分类和量化试验特征,以确定mRNA治疗开发的趋势.
主要成果:
- 总共有557个mRNA临床试验被确定,其中大多数 (73.97%) 在0-3.3阶段.
- 传染病是主要关注 (73.61%),主要涉及mRNA疫苗 (91.02%).
- 工业赞助商主导了资金 (53.68%),北美,亚洲和欧洲是研究的主要地区.
结论:
- 大多数mRNA疗法目前处于预审批临床试验阶段,在2024-2025年早期阶段 (0-1) 试验显著增加.
- 虽然传染病是主要目标,但22项试验正在探索用于罕见疾病的mRNA治疗方法.
- 进一步的第三阶段临床证据至关重要,以支持基于mRNA的治疗方法的更广泛的临床应用.
相关概念视频
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
500
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500
Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K


